Case number 1:25-cv-00188
Otsuka Pharmaceutical Co., Ltd. et al v. Alvogen, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 13, 2025 | N/A | Pro Hac Vice Attorney Jeanette M. Roorda, A. Sasha Hoyt, Melanie Magdun, Laura E. Brashear, James B. Monroe for Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk) (Entered: 06/13/2025) (0) |
| Jun 5, 2025 | N/A | SO ORDERED, re 12 Stipulation and Order to Extend Time for Defendants to move, answer, or otherwise respond to the Complaint to July 7, 2025. (*Reset Answer Deadlines: Almaject, Inc. answer due 7/7/2025; Alvogen, Inc. answer due 7/7/2025). Ordered by Judge Jennifer L. Hall on 6/5/2025. (ceg) (Entered: 06/05/2025) (0) |
| Jun 4, 2025 | 12 | STIPULATION TO EXTEND TIME for Defendants to move, answer, or otherwise respond to the Complaint to July 7, 2025 - filed by Almaject, Inc., Alvogen, Inc.. (Hoeschen, Nathan) (Entered: 06/04/2025) (1) |
| Jun 4, 2025 | 13 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alvogen Pharma US, Inc. for Alvogen, Inc. filed by Alvogen, Inc.. (Hoeschen, Nathan) (Entered: 06/04/2025) (1) |
| Jun 4, 2025 | 14 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alvogen Pharma US, Inc. for Almaject, Inc. filed by Almaject, Inc.. (Hoeschen, Nathan) (Entered: 06/04/2025) (1) |
| May 29, 2025 | N/A | Pro Hac Vice Attorney Erin M. Sommers for Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/29/2025) (0) |
| May 15, 2025 | 9 | MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Erin M. Sommers, Jeanette M. Roorda, Melanie Magdun, A. Sasha Hoyt, and Laura E. Brashear - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 05/15/2025) (8) |
| May 15, 2025 | 10 | Pro Hac Vice Fee - Credit Card Payment received for James B. Monroe, Erin M. Sommers, Jeanette M. Roorda, Melanie Magdun, and A. Sasha Hoyt. ( re 9 MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Erin M. Sommers, Jeanette M. Roorda, Melanie Magdun, A. Sasha Hoyt, and Laura E. Brashear )( Payment of $ 250, receipt number ADEDC-4687654).(Balick, Steven) (Entered: 05/15/2025) (0) |
| May 15, 2025 | 11 | Pro Hac Vice Fee - Credit Card Payment received for Laura E. Brashear. ( re 9 MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Erin M. Sommers, Jeanette M. Roorda, Melanie Magdun, A. Sasha Hoyt, and Laura E. Brashear )( Payment of $ 50, receipt number ADEDC-4687658).(Balick, Steven) (Entered: 05/15/2025) (0) |
| May 15, 2025 | N/A | SO ORDERED, re 9 Motion for Pro Hac Vice Appearance of Attorney James B. Monroe, Erin M. Sommers, Jeanette M. Roorda, Melanie Magdun, A. Sasha Hoyt, and Laura E. Brashear filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Ordered by Judge Jennifer L. Hall on 5/15/2025. (ceg) (Entered: 05/15/2025) (0) |
| May 14, 2025 | 7 | SUMMONS Returned Executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S.Alvogen, Inc. served on 5/14/2025, answer due 6/4/2025. (Balick, Steven) (Entered: 05/14/2025) (2) |
| May 14, 2025 | 8 | SUMMONS Returned Executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S.Almaject, Inc. served on 5/14/2025, answer due 6/4/2025. (Balick, Steven) (Entered: 05/14/2025) (2) |
| Feb 19, 2025 | N/A | Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (nms) (Entered: 02/19/2025) (0) |
| Feb 14, 2025 | 1 | COMPLAINT for Patent Infringement against Almaject, Inc., Alvogen, Inc. (Filing fee $ 405, receipt number ADEDC-4615595) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(mpb) (Entered: 02/18/2025) (0) |
| Feb 14, 2025 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 02/18/2025) (3) |
| Feb 14, 2025 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/6/2025. Date of Expiration of Patent: September 24, 2033 and April 6, 2034.Thirty Month Stay Deadline: 7/6/2027. (mpb) (Entered: 02/18/2025) (2) |
| Feb 14, 2025 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,525,057; 10,980,803; 11,154,553; 11,344,547 ; 11,400,087; 11,648,347. (mpb) (Entered: 02/18/2025) (2) |
| Feb 14, 2025 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (mpb) (Entered: 02/18/2025) (2) |
| Feb 14, 2025 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (mpb) (Entered: 02/18/2025) (2) |
| Feb 14, 2025 | N/A | No Summons Issued. (mpb) (Entered: 02/18/2025) (0) |
